LONG-ACTING GLP-2 ANALOGS
    34.
    发明申请

    公开(公告)号:US20200254065A1

    公开(公告)日:2020-08-13

    申请号:US16787810

    申请日:2020-02-11

    IPC分类号: A61K38/26 A61K47/65 A61K47/60

    摘要: Compositions which include glucagon-like peptide-2 (GLP-2) analogs, GLP-2 analogs with reversible or non-reversible linkers attached to one or more amino acid positions of the GLP-2 analog, and GLP-2 analogs linked to one or more polyethylene glycol polymers (PEG) via reversible or non-reversible linkers are disclosed. Also disclosed are pharmaceutical compositions comprising: the GLP-2 analogs; GLP-2 analogs linked solely to reversible or non-reversible linkers; the reverse PEGylated GLP-2 analogs; and the non-reversibly PEGylated GLP-2 analogs, as well as methods of using the same.